Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Chevron
CVX
|
+$718M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$469M |
| 4 |
Shopify
SHOP
|
+$439M |
| 5 |
Meta Platforms (Facebook)
META
|
+$401M |
Top Sells
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 3 |
Tesla
TSLA
|
+$543M |
| 4 |
Verizon
VZ
|
+$535M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.81% |
| 3 | Consumer Staples | 11.14% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
BBVA Argentina
BBAR
$1.84B
| $514K | ﹤0.01% |
214,930
-102,658
| -32% | -$246K |
|
3152
Nine Energy Service
NINE
$30.5M
| $512K | ﹤0.01% |
193,300
-60,800
| -24% | -$161K |
|
3153
Schwab US Large-Cap Value ETF
SCHV
$13.5B
| $512K | ﹤0.01% |
+24,600
| New | +$512K |
|
|
AAN
3154
DELISTED
The Aaron's Company, Inc.
AAN
| $512K | ﹤0.01% |
35,200
+5,500
| +19% | +$80K |
|
3155
Fidelity D&D Bancorp
FDBC
$267M
| $508K | ﹤0.01% |
+12,482
| New | +$508K |
|
3156
Red River Bancshares
RRBI
$432M
| $508K | ﹤0.01% |
9,400
+300
| +3% | +$16.2K |
|
3157
Vanguard Energy ETF
VDE
$7.29B
| $507K | ﹤0.01% |
+5,100
| New | +$507K |
|
|
SFT
3158
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $507K | ﹤0.01% |
75,270
+5,851
| +8% | +$39.4K |
|
3159
iShares Global Financials ETF
IXG
$581M
| $506K | ﹤0.01% |
7,700
-7,100
| -48% | -$467K |
|
3160
CVD Equipment Corp
CVV
$21.1M
| $505K | ﹤0.01% |
127,782
-3,400
| -3% | -$13.4K |
|
3161
Mastercard
MA
$525B
| $505K | ﹤0.01% |
+1,600
| New | +$505K |
|
3162
Pacific Biosciences
PACB
$351M
| $505K | ﹤0.01% |
114,200
-754,500
| -87% | -$3.34M |
|
3163
Qfin Holdings, Inc. American Depositary Shares
QFIN
$3.76B
| $503K | ﹤0.01% |
+29,100
| New | +$503K |
|
3164
Super Micro Computer
SMCI
$26.7B
| $502K | ﹤0.01% |
124,400
-317,000
| -72% | -$1.28M |
|
3165
Abeona Therapeutics
ABEO
$330M
| $499K | ﹤0.01% |
95,927
+2,894
| +3% | +$15.1K |
|
3166
Emerald Holding
EEX
$980M
| $499K | ﹤0.01% |
122,557
+52,900
| +76% | +$215K |
|
3167
SPDR Dow Jones Global Real Estate ETF
RWO
$1.15B
| $499K | ﹤0.01% |
11,300
-500
| -4% | -$22.1K |
|
3168
Carisma Therapeutics
CARM
$15.6M
| $498K | ﹤0.01% |
30,700
+7,828
| +34% | +$127K |
|
3169
Enliven Therapeutics
ELVN
$1.18B
| $497K | ﹤0.01% |
101,880
-10,745
| -10% | -$52.4K |
|
|
IHT
3170
InnSuites Hospitality Trust
IHT
$17.5M
| $496K | ﹤0.01% |
172,106
-25,089
| -13% | -$72.3K |
|
3171
Autoliv
ALV
$9.68B
| $494K | ﹤0.01% |
6,900
-80,000
| -92% | -$5.73M |
|
|
CALB
3172
DELISTED
California BanCorp Common Stock
CALB
| $493K | ﹤0.01% |
25,585
-5,899
| -19% | -$114K |
|
3173
Integral Ad Science
IAS
$1.4B
| $492K | ﹤0.01% |
+49,500
| New | +$492K |
|
3174
Simplify Interest Rate Hedge ETF
PFIX
$143M
| $491K | ﹤0.01% |
+8,700
| New | +$491K |
|
3175
Q32 Bio
QTTB
$23.5M
| $490K | ﹤0.01% |
13,822
+822
| +6% | +$29.1K |
|